Advertisement

Topics

V710 First-In-Man (FIM) Study (V710-001)

2014-11-19 05:37:09 | BioPortfolio

Published on BioPortfolio: 2014-11-19T05:37:09-0500

Clinical Trials [794 Associated Clinical Trials listed on BioPortfolio]

V710 Clinical Study in Healthy Male Japanese Subjects

This study is to evaluate the safety and ?immunogenicity of V710 in Japanese male subjects.

Safety and Immunogenicity Study of V710 Lyophilized Formulation

This study is being performed to evaluate a single 60 ug dose of lyophilized formulation of Merck S. aureus vaccine (V710) in healthy subjects. This study is intended to provide necessary ...

A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis

This is a study to evaluate the safety and immunogenicity of V710 in patients with end-stage kidney disease on hemodialysis.

A Study of MK3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus

The study investigates the efficacy and safety of MK3009 in patients with skin infections and septicemia caused by MRSA.

Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) to Treatment-experienced HCV Patients

A study to test the safety, tolerability, and efficacy of 4 regimens of vaniprevir + Peg-IFN and RBV as compared to placebo + Peg-IFN and RBV.

PubMed Articles [4271 Associated PubMed Articles listed on BioPortfolio]

A Comparator-Hypothesis Account of Biased Contingency Detection.

Our ability to detect statistical dependencies between different events in the environment is strongly biased by the number of coincidences between them. Even when there is no true covariation between...

Evaluation of linezolid or cotrimoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.

Linezolid or cotrimoxazole plus rifampicin (RIF) are alternative oral treatments for staphylococcal prosthetic joint infections when fluoroquinolones are not possible to use, but there is limited evid...

A glimpse into the future - new therapeutic targets could transform the way we treat staphylococcal infections.

Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Crossover Study Evaluating the Abuse Potential of the Antiepileptic Drug Lacosamide in Healthy Recreational Drug Users.

This phase 1, randomized, double-blind, placebo- and active comparator-controlled crossover study assessed the abuse potential of the antiepileptic drug, lacosamide.

A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects.

To evaluate the analgesic/antihyperalgesic effect of ASP8477.

Medical and Biotech [MESH] Definitions

Infections with bacteria of the genus STAPHYLOCOCCUS.

Infections to the skin caused by bacteria of the genus STAPHYLOCOCCUS.

A diffuse, non-pitting induration of the skin of unknown etiology that occurs most commonly in association with diabetes mellitus, predominantly in females. It typically begins on the face or head and spreads to other areas of the body, sometimes involving noncutaneous tissues. Often it is preceded by any of various infections, notably staphylococcal infections. The condition resolves spontaneously, usually within two years of onset. (From Dorland, 27th ed)

An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.

Poisoning by staphylococcal toxins present in contaminated food.

More From BioPortfolio on "V710 First-In-Man (FIM) Study (V710-001)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial